What is Viatris's developed markets segment — cost of sales?

Viatris (VTRS) reported developed markets segment — cost of sales of $1.01B in Q1 2026.

How has Viatris's developed markets segment — cost of sales changed year-over-year?

Viatris's developed markets segment — cost of sales increased by 9.3% year-over-year, from $926.2M to $1.01B.

What does developed markets segment — cost of sales mean?

The direct costs associated with producing and delivering the pharmaceutical products sold within the developed markets segment, including manufacturing, raw materials, and logistics. This is a primary driver of the segment's gross margin.

Viatris VTRS Developed Markets Segment — Cost of Sales

Similar metrics at other companies

NAG

NAGEPharmaceuticals segment — Cost of Sales

$0—

BAXPharmaceuticals — Cost of Sales

$458M+15.7%

AVOMarketing & Distribution — Segment cost of sales

$256.3M-23.8%

KHCInternational Developed Markets — Other Segment Costs

$135M+10.7%

RTXProducts — Cost of Sales

$13B+5.8%

HPEProducts — Segment cost of sales

$4.84B+33.3%

Other financials

Income statement

See full

Revenue$3.5B+8.1%

Gross profit$1.2B-0.3%

Operating income-$79.7M+97.2%

Net income$176.4M+106%

EPS (diluted)$0.15+106%

Balance sheet

See full

Cash & equivalents$1.8B+139%

Total debt$14.6B+1.0%

Total equity$14.7B-6.3%

Total assets$36.8B-4.3%

Cash flow

See full

Operating cash flow$388.3M-27.5%

CapEx$39.9M-6.3%

Free cash flow$348.4M-29.3%

Valuation

See full

Market cap$18.49B+81.7%

Enterprise value$31.3B+29.5%

P/S1.3×+0.5×

Profitability

See full

Gross margin34.4%-2.5pp

Operating margin1%—

Net margin-2%-1.0pp

FCF margin12.3%-1.0pp

Returns & leverage

See full

Return on equity-2%-0.9pp

Debt / equity1×+0.1×

Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept vtrs:CostOfProductAndServiceSoldAdjusted.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's developed markets segment — cost of sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viatris's developed markets segment — cost of sales?: Viatris (VTRS) reported developed markets segment — cost of sales of $1.01B in Q1 2026.
How has Viatris's developed markets segment — cost of sales changed year-over-year?: Viatris's developed markets segment — cost of sales increased by 9.3% year-over-year, from $926.2M to $1.01B.
What does developed markets segment — cost of sales mean?: The direct costs associated with producing and delivering the pharmaceutical products sold within the developed markets segment, including manufacturing, raw materials, and logistics. This is a primary driver of the segment's gross margin.